David Ross Camidge, Judith Raimbourg, Yun-Gyoo Lee, Maria J. de Miguel, Antoine Hollebecque, Tae Min Kim, Yutaka Fujiwara, François Ghiringhelli, Dae Ho Lee, Jonathan W. Goldman, Mor Moskovitz, Takako Eguchi Nakajima, David Vincente Baz, Zoë Hunter, Michael Charles Burns, Martha Elizabeth Blaney, Rui Li, Tony Navas, Theodore S. Jennaro, David Sommerhalder. "Telisotuzumab adizutecan (ABBV-400; Temab-A), a c-Met protein–targeting antibody-drug conjugate (ADC), in patients (pts) with advanced EGFR -mutated (MT) non-squamous (NSQ) non-small cell lung cancer (NSCLC): Results from a phase 1 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8512